Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study

Documents similaires

• A 2‐Part, Open‐Label, Phase 1 Bioequivalence and Food‐Effect Study of Ubrogepant in Healthy Adult Participants
  par: Ramesh Boinpally, et autres
  Publié: (2025)
• Effect of a High‐Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant Tablet
  par: Ramesh R. Boinpally, et autres
  Publié: (2024)
• Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants
  par: Christian Rask‐Madsen, et autres
  Publié: (2024)
• Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
  par: Matthias Hoch, et autres
  Publié: (2025)
• Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
  par: Shichang Miao, et autres
  Publié: (2024)